Federated Hermes’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
VCM
VPM
Federated Hermes's VRTX Position: Q1 2026 in Review
Federated Hermes reduced its Vertex Pharmaceuticals (VRTX) stake by 7.5% in Q1 2026, selling an estimated $2.72M and leaving 71,822 shares worth $32.1M. The position accounts for 0.05% of the portfolio, ranked #364.
Federated Hermes first reported a position in VRTX in Q2 2013 and has held it in 52 quarters since. The position peaked at $106M in Q2 2020. 1,688 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- Federated Hermes held 71,822 shares of Vertex Pharmaceuticals worth $32.1M as of Q1 2026.
- Federated Hermes sold 5,839 Vertex Pharmaceuticals shares in Q1 2026, an estimated $2.72M.
- Vertex Pharmaceuticals made up 0.05% of Federated Hermes's portfolio in Q1 2026, its #364 holding.
- Federated Hermes first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Federated Hermes's Vertex Pharmaceuticals position peaked at $106M in Q2 2020.
- 1,688 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.